🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Sagar Sengupta, Director, BRIC - National Institute of Biomedical Genomics participated in the Quad Cancer Moonshot Dialogue as a part of the Indian delegation in Delaware US. Department of Biotechnology Rajesh Gokhale Dr Jitendra Singh

Shilpy Sharma CSIR, India HRDGCSIR Shekhar Mande Dr Jitendra Singh Yes, ma'am, you are already aware of my situation, and this is the 10 month we are stepping in and I have not yet received a single penny from the CSIR. I'm not sure, if CSIR knows how to stay in an another city for 10 months without money Dr Jitendra Singh HRDGCSIR CSIR, India

Shilpy Sharma muskan osley CSIR, India HRDGCSIR Dr Jitendra Singh Although I don't work with the Govt any more, and there was a recommendation by my committee during my last phase at CSIR to solve this, I believe those recommendations were eventually not implemented. Let me take it up with relevant authorities one again.

We encourage eligible candidates to apply for the following positions 1. Assistant Professor 2. Technical Assistant/Senior Laboratory Technician 3. Senior Manager (Administration & Finance) Visit our website for more info Apply by 📅7th Oct 2024 To apply🔗apply.nibmg.ac.in

Looking for a motivated non-NET Master’s graduate willing to work on a fully funded project by Department of Biotechnology at BRIC - National Institute of Biomedical Genomics . Prior experience in molecular biology techniques like qPCR, cell culture, FACS and knowledge of Epigenetics is a bonus. Interested may Repost or DM.

🚨 The most powerful rocket ever built has taken to the skies again, but this time, it came back. SpaceX's Starship! Elon Musk 👏

Today, as #GatiShakti completed three years, went to Bharat Mandapam and visited the Anubhuti Kendra, where I experienced the transformative power of this initiative.

Warm greetings and good wishes on the occasion of #GuruGobindSinghJayanti. I am sharing one of my sand art 🙏

As I bid farewell to India after serving as the 26th U.S. Ambassador to this amazing country, my heart is full. You’ve given me a second home, a family of friends, and memories that will last a lifetime. Today, I leave as more than an ambassador—I leave as a lifelong friend and

Just Published!🔥 #𝐂𝐚𝐧𝐜𝐞𝐫𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐝𝐟𝐢𝐛𝐫𝐨𝐛𝐥𝐚𝐬𝐭𝐬 𝐚𝐬 𝐚 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐧𝐨𝐯𝐞𝐥 #𝐥𝐢𝐪𝐮𝐢𝐝𝐛𝐢𝐨𝐩𝐬𝐲 𝐦𝐚𝐫𝐤𝐞𝐫 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 Enjoy your reading🍷 jeccr.biomedcentral.com/articles/10.11… #Bloodbasedbiomarkers #Circulatingtumorcells

Prof. Sandeep Singh’s lab has discovered stromal CAFs with endothelial-like state, reprogram oral cancer cells to an embryonic-like state—driving stemness and poor prognosis in patients. 🧬🧫 Published in Journal of Experimental & Clinical Cancer Research: bit.ly/3S2LIPH

Many thanks to BRIC - National Institute of Biomedical Genomics and Department of Biotechnology for supporting the work. Special mention Arindam Maitra Mohit Kumar Jolly and all other collaborators for their effort in shaping the work. #Collaboration #CancerResearch

In a landmark initiative with far reaching futuristic implications, the Union Cabinet headed by the Hon’ble Prime Minister Shri Narendra Modi approved the BioE3 (Biotechnology for Economy, Employment and Environment) Policy of the Department of Biotechnology #DBT to foster

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics dlvr.it/TKm6gd

BRIC BRIC - National Institute of Biomedical Genomics researchers explored the role of Tunica Interna Endothelial Cell Kinase (Tie2/TEK) signaling in transition and maintenance of myofibroblastic phenotype of #CAFs, providing wider applicability of Tie2-specific functions in tumor biology, along with its known

#DBTIndia Update The Govt of India has amended GFR 2017 for scientific Ministries including Department of Biotechnology, raising procurement limits for equipment and consumables. Vice-Chancellors/Directors can approve Global Tenders up to ₹200 crore for justified research. These changes will

A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies dlvr.it/TLG12q

Join the open webinar tomorrow to know more about the #i3c BRIC-RCB PhD program in Biosciences Dr Jitendra Singh Rajesh Gokhale

#India is charting a new course in healthcare with #BioE3policy- advancing precision therapeutics through novel gene therapies that are targeted and catered to the individual's profile. Tailored treatments are turning real for India, as #precisiontherapeutics make headway with

📢 Indian scientists abroad - 🇮🇳 is calling! Apply for prestigious Anusandhan National Research Foundation Ramanujan Fellowship, choose Ashoka University as host. Lead your own lab, do cutting-edge research & build a career. Read More: linkedin.com/feed/update/ur… Pramath Raj Sinha | प्रमथ राज सिन्हा Somak Raychaudhury Anurag Agrawal K. VijayRaghavan